Customers are being warned of a choking risk related to dosing syringes in some batches of children’s Panadol.
The Therapeutic Goods Administration said the issue relates to Panadol Children 20ml, for children aged one month to one year, expiring at various times this year.
The manufacturer, Haleon Australia, said the dosing syringe may be stiff, making it difficult for parents to control the delivery of medicine.
Newsletters: Breaking news as it happens. Subscribe now
The TGA warned this poses a choking risk, particularly for babies.
Customers have been advised to dispose of the supplied syringe and get an alternative from a pharmacy.
The list of affected batches can be found here, and below.
The affected batch numbers for the 20mL bottle are:
- DR562 (expiry 30/04/2024)
- DR563 (expiry 30/04/2024)
- DT528 (expiry 30/04/2024)
- DS947 (expiry 31/07/2024)
- DS956 (expiry 31/08/2024)
- DT334 (expiry 30/09/2024)
- DT469 (expiry 30/09/2024)
- DT762 (expiry 31/10/2024)
- DT912 (expiry 31/10/2024)
- DU128 (expiry 30/11/2024)
- DT913 (expiry 31/10/2024)
- DW301 (expiry 28/02/2025)
- DW507 (expiry 28/02/2025)
- DW487 (expiry 28/02/2025)
Denial of responsibility! Swift Telecast is an automatic aggregator of the all world’s media. In each content, the hyperlink to the primary source is specified. All trademarks belong to their rightful owners, all materials to their authors. If you are the owner of the content and do not want us to publish your materials, please contact us by email – swifttelecast.com. The content will be deleted within 24 hours.